The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Oncolytic Virus Therapy Market From 2026 To 2030?
The oncolytic virus therapy market has experienced substantial expansion in recent years. Its value is projected to increase from $0.23 billion in 2025 to $0.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.7%. The growth observed in the preceding period can be attributed to various factors, including the development of hsv- and adenovirus-based oncolytic therapies, early clinical trials targeting melanoma and breast cancer, increasing interest from cancer research institutes, rising government funding for virotherapy research, and an increase in collaborations between biotech companies and academic institutions.
The oncolytic virus therapy market is poised for significant expansion in the coming years. This market is projected to reach $0.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.7%. This anticipated growth during the forecast period is fueled by several factors, including an escalating demand for genetically engineered oncolytic viruses, their increasing application in treating lung, prostate, and brain cancers, the proliferation of specialized clinics and hospitals providing virotherapy, increased investments in developing combination and novel virus therapies, and the expansion of clinical trial facilities in developing regions. Key trends anticipated during this period encompass the growing integration of AI and big data in oncolytic virus research, enhanced utilization of genomics and precision medicine for designing therapies, wider adoption of digital platforms for overseeing clinical trials, increased automation in the production and quality assurance of viruses, and the expanding deployment of IoT-based systems for monitoring virus storage and distribution.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp
Which Primary Drivers Are Impacting The Oncolytic Virus Therapy Market Growth?
The oncolytic virus therapy market is anticipated to expand due to the rising occurrence of cancer cases. Cancer refers to a collection of illnesses defined by the uncontrolled proliferation and dissemination of atypical cells throughout the body. Oncolytic virus therapy provides a means to specifically identify and eliminate cancer cells, concurrently activating an immune reaction against the tumor, thereby offering a two-pronged approach for successful cancer treatment. As an example, the World Health Organization, an intergovernmental body based in Switzerland, reported in February 2024 that more than 35 million new cancer cases are forecast by 2050, marking a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing incidence of cancer cases is fueling the expansion of the oncolytic virus therapy market.
What Are The Key Segment Divisions In The Oncolytic Virus Therapy Market Segment Structure?
The oncolytic virus therapy market covered in this report is segmented –
1) By Therapy Type: Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease Virus (NDV), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes
Subsegments:
1) By Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy: Genetically Modified Herpes Simplex Virus Oncolytic Viruses, T-VEC (Talimogene Laherparepvec) Therapy, Herpes Simplex Virus-Based Combination Therapies, Herpes Simplex Virus-Based Targeted Oncolytic Approaches
2) By Adenovirus-Based Oncolytic Virus Therapy: Conditionally Replicating Adenoviruses, Oncolytic Adenovirus Immunotherapies, Adenovirus-Based Combination Treatments, Targeted Adenovirus Therapies
3) By Reovirus: Reolysin Therapy, Genetically Engineered Reoviruses, Reovirus Combination Treatments, Tumor-Selective Reovirus Approaches
4) By Poxviruses: Vaccinia Virus-Based Oncolytic Therapies, Modified Vaccinia Ankara (MVA) Therapies, Poxvirus Combination Treatments, Tumor-Targeted Poxvirus Therapies
5) By Newcastle Disease Virus (NDV): Wild-Type Newcastle Disease Virus Therapies, Genetically Modified Newcastle Disease Virus Oncolytic Approaches, Newcastle Disease Virus Combination Therapies, Tumor-Selective Newcastle Disease Virus Treatments
6) By Other Therapy Types: Measles Virus-Based Oncolytic Therapies, Vesicular Stomatitis Virus (VSV) Therapies, Other Experimental Oncolytic Virus Treatments, Emerging Oncolytic Virus Platforms
Which Trends Are Shaping Growth In The Oncolytic Virus Therapy Market?
Leading companies in the oncolytic virus therapy market are prioritizing the attainment of regulatory approvals to accelerate the introduction of novel therapies for cancer treatment. Regulatory approvals signify the process by which health authorities evaluate and authorize medical products, including drugs, biologics, and medical devices, for market use. For example, in March 2024, ImmVira, a biotechnology company based in China, secured Fast Track designation from the FDA for its oncolytic virus therapy, MVR-T3011 IT. This therapy is intended for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients who have shown disease progression after platinum-based chemotherapy and at least one previous line of anti-PD-1/PD-L1 therapy. This designation aims to expedite the development and review pathways for therapies addressing serious conditions with unfulfilled medical requirements.
Which Organizations Are Engaged In The Oncolytic Virus Therapy Market?
Major companies operating in the oncolytic virus therapy market are Sorrento Therapeutics Inc., Amgen Inc., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Provectus Biopharmaceuticals Inc., Vibalogics, Turnstone Biologics, PsiOxus Therapeutics Ltd., Targovax, Cold Genesys, Shanghai Sunway Biotech Co Ltd., Neotropix, Candel Therapeutics Inc., CG Oncology, DNAtrix Inc., Oryx GmbH, ViroCure, GeneMedicine, VCN Biosciences, Beijing Syngentech, KaliVir Immunotherapeutics Inc.
Get The Full Oncolytic Virus Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
Which Region Is The Largest In The Oncolytic Virus Therapy Market?
North America was the largest region in the oncolytic virus therapy market in 2025 and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Oncolytic Virus Therapy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
Browse Through More Reports Similar to the Global Oncolytic Virus Therapy Market 2026, By The Business Research Company
Clinical Nutrition For Cancer Care Market Report 2026
Oncology Drugs Market
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Oncology Drugs Market
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model